After a second attack in 1989, she received an artificial pacemaker.

After a hospital stay she was fitted with a artificial pacemaker and released.

One important feature is the ability of the artificial pacemaker to speed up the heart rate in response to activity.

Artificial pacemakers have been used in the treatment of sick sinus syndrome.

It is also used for long life batteries as required, for example, by artificial pacemakers.

In October 1981, Schmidt was fitted with a artificial pacemaker.

If these cells are damaged by disease, the implantation of an artificial pacemaker becomes necessary.

He was subsequently fitted with an artificial pacemaker to help regulate his heartbeat.

A permanent artificial pacemaker may be placed in situations where the bradycardia is not expected to recover.

However it was Hyman who used and popularised the term "artificial pacemaker", which remains in use to this day.

These people can use drugs, intubation, artificial pacemakers and defibrillation to achieve this result.

Hyman himself referred to his invention as an "artificial pacemaker", the term continuing in use to this day.

An investigation showed the ride was operating correctly and was not the cause of his death; he had an artificial pacemaker.

Some people with heart failure are treated with an artificial pacemaker that makes the heart work better.

These devices are implants, similar to artificial pacemaker (and many can also perform the pacemaking function).

Examples of such instruments include scalpels, hypodermic needles and artificial pacemakers.

The treatment for diffuse distal conduction system disease is insertion of a artificial pacemaker.

A temporary artificial pacemaker was applied to Evren while in intensive care due to bradycardia.

An artificial pacemaker stabilizes the system by taking over the job of sending out electrical impulses, getting the heart back into a regular rhythm.

When this is a problem, an operation is often performed to install an artificial pacemaker, which takes over the role of the sinoatrial node.

In the early 1960s, Kantrowitz developed an implantable artificial pacemaker together with General Electric.

The initial commercial artificial pacemaker, under the patent in 1972, used stainless steel as a non-hermetic encasing medium.

Third-degree AV block can be treated by use of a dual-chamber artificial pacemaker.

When the first artificial pacemakers for the human heart were developed about 30 years ago, the sole objective was to save the patient from unpredictable sudden death.

An artificial pacemaker mimics the electrical impulses normally created by the SA node.